Optimi Health Corp. (NASDAQ:OPTH) Short Interest Down 71.2% in July

Optimi Health Corp. (NASDAQ:OPTH) saw a significant drop in short interest in July. As of July 31st, there was short interest totaling 20,776 shares, a drop of 71.2% from the July 15th total of 72,205 shares. Based on an average daily volume of 34,203 shares, the days-to-cover ratio is presently 0.6 days. Currently, 0.4% of the company’s stock are sold short.

Optimi Health Stock Performance

Shares of OPTH opened at $4.75 on Thursday. Optimi Health has a 12 month low of $4.00 and a 12 month high of $6.40. The firm’s fifty day simple moving average is $4.70. The company has a debt-to-equity ratio of 0.04, a quick ratio of 0.03 and a current ratio of 0.06. The stock has a market cap of $27.22 million and a price-to-earnings ratio of -13.19.

Wall Street Analysts Forecast Growth

A number of equities analysts have commented on the stock. Wall Street Zen upgraded shares of Optimi Health to a “hold” rating in a report on Saturday, July 25th. Zacks Research raised shares of Optimi Health to a “hold” rating in a research report on Thursday, May 28th. Finally, Weiss Ratings assumed coverage on shares of Optimi Health in a research note on Thursday, May 21st. They set a “sell (d-)” rating for the company. One analyst has rated the stock with a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Reduce”.

Optimi Health Company Profile

Optimi Health Corp. is a commercial-stage pharmaceutical company focused on manufacturing and distributing GMP-grade psychedelic drug products for mental health therapies. Optimi Health Corp. is based in VANCOUVER, BC.